课题基金 / 基金详情

Insulin action in human cardiac and skeletal muscle microvasculature

Insulin action in human cardiac and skeletal muscle microvasculature
胰岛素在人体心脏和骨骼肌微血管中的作用
批准号:
8625818
负责人:
ZHENQI LIU
金额:
$37.35万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-15 至 2016-01-31

项目摘要

项目成果

ZHENQI LIU的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Patients with type 2 diabetes mellitus (T2DM) frequently develop cardiovascular complications which contribute significantly to morbidity and mortality. Insulin resistance and endothelial dysfunction are two cardinal features of T2DM. Whether microvascular insulin resistance contributes to the increased cardiovascular morbidity and mortality in patients with T2DM remains to be defined. T2DM is associated with humoral and inflammatory changes that can cause insulin resistance and endothelial dysfunction. Among them, elevation of plasma free fatty acids (FFAs) and over-activation of the renin-angiotensin system (RAS) are thought to play pivotal roles in vascular insulin resistance and endothelial dysfunction, and in the increased cardiovascular morbidity and mortality of diabetes. In the proposed studies, we will test the hypotheses that: 1) elevation of plasma FFAs blunts insulin-mediated cardiac and skeletal muscle microvascular perfusion and glucose uptake by activating inflammatory signaling and increasing endothelin 1 (ET- 1) secretion/action; 2) AT1R blockade increases cardiac and skeletal muscle microvascular perfusion, augments insulin-mediated glucose uptake, and attenuates FFA-induced dysfunction in the coronary and skeletal muscle microcirculation in healthy humans; and 3) patients with diabetes have decreased coronary microvascular flow reserve and blunted vasodilatory response upon insulin stimulation in the cardiac and skeletal muscle microvasculature, and that these abnormalities are corrected with anti-inflammatory therapy and/or AT1R blockade. We will quantify cardiac and skeletal muscle microvascular perfusion in healthy and diabetic humans and examine the potential mechanisms underlying microvascular insulin resistance. Results from the proposed studies should help to define the mechanisms underlying insulin resistance in cardiac and skeletal muscle microvasculature in diabetic humans and open a new avenue for future mechanistic, diagnostic and/or therapeutic studies.
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.tcm.2014.08.001
发表时间: 2014-11
期刊: TRENDS IN CARDIOVASCULAR MEDICINE
影响因子: 9.3
作者: [Zhao, Lina, Fu, Zhuo, Liu, Zhenqi]
通讯作者: Liu, Zhenqi
DOI: 10.1161/hypertensionaha.113.03025
发表时间: 2014-06
期刊: Hypertension (Dallas, Tex. : 1979)
影响因子: --
作者: [Fu Z, Zhao L, Aylor KW, Carey RM, Barrett EJ, Liu Z]
通讯作者: Liu Z
DOI: 10.1042/cs20130708
发表时间: 2014-08
期刊: Clinical science (London, England : 1979)
影响因子: --
作者: [Subaran SC, Sauder MA, Chai W, Jahn LA, Fowler DE, Aylor KW, Basu A, Liu Z]
通讯作者: Liu Z
DOI: 10.2337/db11-1073
发表时间: 2012-04
期刊: Diabetes
影响因子: 7.7
作者: [Chai W, Dong Z, Wang N, Wang W, Tao L, Cao W, Liu Z]
通讯作者: Liu Z
12
    Role of Microvascular insulin resistance and cardiorespiratory fitness in diabetes
    • 批准号:
      10371154
    • 项目类别:
    • 资助金额:
      $71.19万
    • 财政年份:
      2021
    • 负责人:
      ZHENQI LIU
    • 依托单位:
    Role of Microvascular insulin resistance and cardiorespiratory fitness in diabetes
    • 批准号:
      10212038
    • 项目类别:
    • 资助金额:
      $69.51万
    • 财政年份:
      2021
    • 负责人:
      ZHENQI LIU
    • 依托单位:
    Effects of Exercise and GLP-1R Agonism on Muscle Microvascular Perfusion and Insulin Action
    • 批准号:
      10170355
    • 项目类别:
    • 资助金额:
      $65.68万
    • 财政年份:
      2020
    • 负责人:
      ZHENQI LIU
    • 依托单位:
    Effects of Exercise and GLP-1R Agonism on Muscle Microvascular Perfusion and Insulin Action
    • 批准号:
      10027190
    • 项目类别:
    • 资助金额:
      $65.68万
    • 财政年份:
      2020
    • 负责人:
      ZHENQI LIU
    • 依托单位:
    国内基金
    海外基金
    膀胱癌细胞通过调控淋巴内皮细胞angiopoietin-2修饰促进淋巴转移的分子机制研究
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      54.7万元
    • 批准年份:
      2021
    • 负责人:
      何旺
    • 依托单位:
    中药单体蟾毒灵调控Angiopoietin-2蛋白分泌抑制肝癌血管生成的分子机制研究
    • 批准号:
      81603348
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      17.0万元
    • 批准年份:
      2016
    • 负责人:
      王海永
    • 依托单位:
    肿瘤包绕型血管关键分子Angiopoietin-2在肝癌的表达调控机制及其功能
    • 批准号:
      81602151
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      18.0万元
    • 批准年份:
      2016
    • 负责人:
      周慧超
    • 依托单位:
    炎症与淋巴管再生: Angiopoietin-2的调控作用
    • 批准号:
      30772262
    • 项目类别:
      面上项目
    • 资助金额:
      30.0万元
    • 批准年份:
      2007
    • 负责人:
      刘宁飞
    • 依托单位: